Security
NBRV · Nabriva Therapeutics plc
NBRVOTCCommon stockHistorical · closed Jul 31, 2023CIK 1641640Updated Sep 25, 2026
Name history
Nabriva Therapeutics AG · through Jul 10, 2017
NBRV price & chart
Historical security
This listing closed Jul 31, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 31,765,000Source | 80,909,000Source | 58,436,000Source | 94,113,000Source |
| Property, Plant and Equipment, NetUSD | 280,000Source | 233,000Source | 768,000Source | 2,474,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 3,000Source | 31,000Source | 80,000Source | 91,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 12,414,000Source | 47,659,000Source | 41,359,000Source | 86,019,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 3,208,000Source | 8,778,000Source | — | — |
| Inventory, NetUSD | 9,676,000Source | 14,509,000Source | 5,823,000Source | 682,000Source |
| Assets, CurrentUSD | 31,104,000Source | 80,265,000Source | 57,218,000Source | 91,170,000Source |
| Other Assets, NoncurrentUSD | 378,000Source | 380,000Source | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 28,472,000Source | 27,559,000Source | 25,301,000Source | 52,839,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 32,000Source | 567,000Source | 211,000Source | 945,000Source |
| Retained Earnings (Accumulated Deficit)USD | -652,861,000Source | -595,676,000Source | -546,226,000Source | -476,742,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 27,000Source | 27,000Source | 27,000Source | 27,000Source |
| Stockholders' Equity Attributable to ParentUSD | 3,293,000Source | 53,350,000Source | 33,135,000Source | 41,274,000Source |
| Additional Paid in Capital, Common StockUSD | 656,095,000Source | 648,432,000Source | 579,123,000Source | 517,044,000Source |
| Liabilities and EquityUSD | 31,765,000Source | 80,909,000Source | 58,436,000Source | 94,113,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 27,605,000Source | 22,340,000Source | 18,524,000Source | 16,639,000Source |
| Accounts Payable, CurrentUSD | 5,431,000Source | 4,372,000Source | 2,889,000Source | 4,673,000Source |
| Other Liabilities, NoncurrentUSD | 479,000Source | 954,000Source | 1,091,000Source | 1,698,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 17,341,000Source | 13,829,000Source | 12,844,000Source | 11,966,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | 47,900,000Source | 41,600,000Source | 86,600,000Source |
| Long-term Debt, Current MaturitiesUSD | 4,833,000Source | 3,765,000Source | 2,041,000Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 388,000Source | 4,265,000Source | 5,686,000Source | 34,502,000Source |
| Short-term InvestmentsUSD | — | 16,000Source | 16,000Source | 175,000Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -57,185,000Source | -49,450,000Source | -69,484,000Source | -82,764,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 217,000Source | 356,000Source | 417,000Source | 396,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,967,000Source | 3,291,000Source | 5,219,000Source | 9,748,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | -4,833,000Source | 8,686,000Source | 5,141,000Source | 682,000Source |
| Increase (Decrease) in Accounts PayableUSD | 1,093,000Source | 1,581,000Source | -1,813,000Source | 1,310,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -36,711,000Source | -59,557,000Source | -71,331,000Source | -71,892,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -263,000Source | -81,000Source | -274,000Source | 331,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 1,851,000Source | 66,366,000Source | 26,924,000Source | 56,075,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -35,297,000Source | 6,244,000Source | -44,821,000Source | -15,592,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 12,537,000Source | 47,834,000Source | 41,590,000Source | 86,411,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 406,000Source | 497,000Source | 1,396,000Source | 2,560,000Source |
| Income Taxes Paid, NetUSD | -1,000,000Source | -513,000Source | 4,000Source | 11,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -174,000Source | -484,000Source | -140,000Source | -106,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 1,967,000Source | 3,291,000Source | 5,219,000Source | 9,748,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | 47,900,000Source | 41,600,000Source | 86,600,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -2,757,000Source | — |
| Income Tax Expense (Benefit)USD | 1,568,000Source | 490,000Source | 139,000Source | 101,000Source |
| Investment Income, InterestUSD | — | — | 86,000Source | 255,000Source |
| Net Income (Loss) Attributable to ParentUSD | -57,185,000Source | -49,450,000Source | -69,484,000Source | -82,764,000Source |
| Operating Lease, ExpenseUSD | — | — | 1,400,000Source | 1,500,000Source |
| Other Nonoperating Income (Expense)USD | 571,000Source | 469,000Source | 1,187,000Source | 215,000Source |
| Payments for Repurchase of WarrantsUSD | 406,000Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | 3,460,000Source | 42,280,000Source | 7,520,000Source | — |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | 9,980,000Source |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | 36,935,000Source | 28,895,000Source | 5,027,000Source | 9,481,000Source |
| Cost of RevenueUSD | — | — | 766,000Source | 70,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 45,264,000Source | 51,645,000Source | 55,285,000Source | 62,485,000Source |
| Operating Income (Loss)USD | -55,490,000Source | -48,528,000Source | -66,126,000Source | -79,489,000Source |
| Other Nonoperating Income (Expense)USD | 571,000Source | 469,000Source | 1,187,000Source | 215,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -55,617,000Source | -48,960,000Source | -69,345,000Source | -82,663,000Source |
| Income Tax Expense (Benefit)USD | 1,568,000Source | 490,000Source | 139,000Source | 101,000Source |
| Net Income (Loss) Attributable to ParentUSD | -57,185,000Source | -49,450,000Source | -69,484,000Source | -82,764,000Source |
| Earnings Per Share, BasicUSD per share | -21.32Source | -1.14Source | — | — |
| Earnings Per Share, DilutedUSD per share | -21.32Source | -1.14Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 2,681,968Source | 43,349,461Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 2,681,968Source | 43,349,461Source | — | — |
| Additional Financial Items | ||||
| Costs and ExpensesUSD | 92,425,000Source | 77,423,000Source | 71,153,000Source | 88,970,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -54,235,000Source | -40,540,000Source | -71,344,000Source | -78,761,000Source |
| Interest ExpenseUSD | 698,000Source | 901,000Source | 1,735,000Source | 3,644,000Source |
| Investment Income, InterestUSD | — | — | 86,000Source | 255,000Source |
| Operating Lease, ExpenseUSD | — | — | 1,400,000Source | 1,500,000Source |
| Research and Development ExpenseUSD | 14,263,000Source | 12,630,000Source | 15,102,000Source | 26,415,000Source |